AXGN AxoGen, Inc.

AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries.

$19.85  +0.18 (0.92%)
As of 07/23/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2003
Outstanding shares:  41,003,269
Average volume:  127,919
Market cap:   $806,534,301
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    05463X106
ISIN:        US05463X1063
Sedol:      B7254K9
Valuation   (See tab for details)
PE ratio:   -36.57
PB ratio:   6.77
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy